Trastuzumab Cardiotoxicity in Patients with Breast Cancer
Dear Editor,
We read the article “Detection of Subclinical Trastuzumab-Induced Cardiotoxicity in Patients with Breast Cancer”. Cardio-oncology is a current challenge for cardiologists, due to the high prevalence of cardiovascular toxicity secondary to chemotherapy agents, in addition to the need to determine effective measures to reduce the incidence of that complication – .
[…]
Comments are moderated by the editorial team before publication. Discussions should be evidence-based and use scientific language. Conflicts of interest should be declared.